{"id":"W2169012257","doi":"10.1016/s1470-2045(15)70056-2","title":"Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":220,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Medical Association; University of Alberta","funders":"Merck","keywords":"Vorinostat; Tolerability; Medicine; Internal medicine; Placebo; Population; Oncology; Adverse effect; Surgery; Histone deacetylase; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00151488,0.000376136,0.001076533,0.0001403864,0.00009811189,0.00003805727,0.0005544655,0.0002690235,0.0000211816],"category_scores_gemma":[0.0002302053,0.0002311846,0.0001475499,0.0001825684,0.0002826475,0.00001198229,0.000101719,0.0003895996,0.00001761721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001893616,"about_ca_system_score_gemma":0.0004907615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002195943,"about_ca_topic_score_gemma":0.0001739518,"domain_scores_codex":[0.9966799,0.0008816706,0.0005562669,0.0006184459,0.000494488,0.0007692252],"domain_scores_gemma":[0.9983164,0.000158044,0.0003318974,0.0007790076,0.0002194859,0.0001951759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.985701,0.001669361,0.000497922,0.00001636683,0.0001758023,0.0000536141,0.0004374164,0.0001487677,0.003966078,0.00001545441,0.003401328,0.003916871],"study_design_scores_gemma":[0.937817,0.01508037,0.00006397434,0.00003977272,0.00003734029,0.00001133701,0.00006956158,0.000129155,0.02861259,0.00001108241,0.017836,0.0002918412],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867711,0.0002787573,0.00003416266,0.0009120066,0.0002687158,0.009505991,0.00004255896,0.00002921322,0.002157502],"genre_scores_gemma":[0.9945743,0.00009825647,0.0002020409,0.0005430324,0.000811387,0.002510278,0.0001758392,0.00007432574,0.00101055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04788403,"threshold_uncertainty_score":0.9427434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03588223247442272,"score_gpt":0.360391855471871,"score_spread":0.3245096229974483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}